AKT1 and cancer: Mechanistic studies have shown that inhibiting cancer-IgG expression affects the PI3K/AKT/DNA-PKcs pathway to downregulate the expression of repair proteins, inhibit the DSB damage and repair of LUAD cells, and enhance the radiosensitivity.